EZ-Log vs Advoy
While other options for infusion data collection exist, studies show that EZ-Log provides the features hemophilia patients and caregivers want in an electronic diary system.
The EZ-Log Survey
At the 55th Annual National Hemophilia Foundation Meeting in Salt Lake City, Utah, in 2003, a market research initiative was undertaken to obtain feedback on the EZ-Log electronic patient diary. The research was conducted in the form of a closed-ended survey questionnaire immediately following the product demonstration at the Bayer HealthCare booth.
Survey Key Findings:
Almost all survey respondents preferred the EZ-Log mobile application to an available Internet-based infusion data collection system.
Current Advoy users found EZ-Log superior to Advoy.
"Compared to the paper bleed diaries, the patient record using EZ-Log is 70% more complete."
Hemophilia Nurse, Hamilton, Ontario, Canada
Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.
Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.
